Groowe Groowe / Newsroom / TEVA
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

TEVA News

Teva Pharmaceutical Industries Limited American Depositary Shares

Community Routes: Access to Mental Health Care Provides Continued Funding for Mental Health Services at Free & Charitable Clinics

globenewswire.com
TEVA

Francois Schramek Promoted to Partner at Manhattan West

prnewswire.com
AI AMN GM LMT NVDA GOOG MSFT SPCE RKLB GD BA AMD INTC META CRWD PLTR AN DD HON RTX IBM AMZN TSLA XOM CVX UNH BMY PFE MRK JNJ LLY GILD REGN BIIB AMGN AZN NVO SNY TEVA BABA JD NTES BIDU IQ VIPS BZUN HTHT MELI BBD BB ERIC NOK QCOM MU ADSK CRM GOOGL

Medincell : Information relative au nombre d’actions composant le capital social et au nombre total des droits de vote

businesswire.com
TEVA

Liposomal Doxorubicin Market Insights Report 2026: Cancer Incidence Surge Fuels Market Growth, Asia-Pacific Emerges as Fastest-Growing Region

globenewswire.com
JNJ PFE TEVA

Sorafenib Market Research Report 2026-2030 - Increasing Cancer Incidence Spurs Sorafenib Market Expansion

globenewswire.com
TEVA

Capecitabine Market Outlook 2026-2030 Shows 9% CAGR as Innovations in Therapies and Homecare Treatment Adoption Accelerate Industry Growth

globenewswire.com
TEVA

Teva Gains Biosimilar Momentum with U.S. FDA Approval of PONLIMSI™ (denosumab-adet) and Dual Filing Acceptance for Biosimilar Candidate to Xolair® (omalizumab)

globenewswire.com
TEVA

$28+ Billion Cancer Supportive Care Products Market Outlook Report, 2030

globenewswire.com
JNJ MRK ABBV ABT NVS GSK AMGN TEVA JAGX LLY

Neuroprotective Agents Market to Reach $60.9 Billion by 2030 as Neurological Disease Burden and Aging Populations Drive Pharmaceutical Investment

globenewswire.com
ABBV AZN BIIB BMY GSK LLY MRK NVS SNY TEVA UCB

EIB Waives its Right to Cash Settlement on Medincell Warrants

businesswire.com
TEVA